NKG2A&CD94[Biotin], His & Avi & Flag, Human
NKG2A&CD94[Biotin], His & Avi & Flag, Human

Immobilized NKG2A&CD94[Biotin], His & Avi & Flag, Human, His Tag at 1 μg/ml (100 μI/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-NKG2A Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.

NKG2A&CD94[Biotin], His & Avi & Flag, Human

The purity of NKG2A&CD94[Biotin], His & Avi & Flag, Human is greater than 95% as determined by SEC-HPLC.

NKG2A&CD94[Biotin], His & Avi & Flag, Human

NKG2A&CD94[Biotin], His & Avi & Flag, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

NKG2A&CD94[Biotin], His & Avi & Flag, Human

The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies.
Z04566
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
His&Avi&Flag NKG2A & CD94 [Arg100-Leu233 (NKG2A) & Ser34-Ile179 (CD94)]
Accession # P26715-1 (NKG2A) & Q13241-1 (CD94)
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 17.9 kDa (CD94)&18.3 kDa (NKG2A)
Apparent Molecular Weight Due to glycosylation, the protein migrates to 33-48 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • NKG2A&CD94[Biotin], His & Avi & Flag, Human
    • NKG2A&CD94[Biotin], His & Avi & Flag, Human

    Immobilized NKG2A&CD94[Biotin], His & Avi & Flag, Human, His Tag at 1 μg/ml (100 μI/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-NKG2A Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.

  • NKG2A&CD94[Biotin], His & Avi & Flag, Human
    • NKG2A&CD94[Biotin], His & Avi & Flag, Human

    The purity of NKG2A&CD94[Biotin], His & Avi & Flag, Human is greater than 95% as determined by SEC-HPLC.

  • NKG2A&CD94[Biotin], His & Avi & Flag, Human
    • NKG2A&CD94[Biotin], His & Avi & Flag, Human

    NKG2A&CD94[Biotin], His & Avi & Flag, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies.
Synonyms CD159a; NKG2A; NKG2-A; CD94; NKG2A&CD94

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.